Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis

Rongjun He, Zhi Hong Yu, Ruo Yu Zhang, Li Wu, Andrea M. Gunawan, Zhong-Yin Zhang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

mPTPB is a virulent phosphatase from Mycobacterium tuberculosis and a promising therapeutic target for tuberculosis. To facilitate mPTPB-based drug discovery, we identified α-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation β-lactam cephalosporin antibiotic, as a novel pTyr pharmacophore for mPTPB. Structure-guided and fragment-based optimization of SPAA led to the most potent and selective mPTPB inhibitor 9, with a Ki of 7.9 nM and more than 10,000-fold preference for mPTPB over a large panel of 25 phosphatases. Compound 9 also exhibited excellent cellular activity and specificity in blocking mPTPB function in macrophage. Given its novel structure, modest molecular mass, and extremely high ligand efficiency (0.46), compound 9 represents an outstanding lead compound for anti-TB drug discovery targeting mPTPB.

Original languageEnglish (US)
Pages (from-to)1231-1235
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume6
Issue number12
DOIs
StatePublished - Dec 10 2015

Fingerprint

Cefsulodin
Drug Discovery
Mycobacterium tuberculosis
Phosphoric Monoester Hydrolases
Amides
Lead compounds
Lactams
Macrophages
Molecular mass
Cephalosporins
Drug Delivery Systems
Molecular Structure
Tuberculosis
Ligands
Therapeutics

Keywords

  • antituberculosis
  • mPTPB inhibitor
  • Protein tyrosine phosphatase
  • pTyr mimetics

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis. / He, Rongjun; Yu, Zhi Hong; Zhang, Ruo Yu; Wu, Li; Gunawan, Andrea M.; Zhang, Zhong-Yin.

In: ACS Medicinal Chemistry Letters, Vol. 6, No. 12, 10.12.2015, p. 1231-1235.

Research output: Contribution to journalArticle

He, Rongjun ; Yu, Zhi Hong ; Zhang, Ruo Yu ; Wu, Li ; Gunawan, Andrea M. ; Zhang, Zhong-Yin. / Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis. In: ACS Medicinal Chemistry Letters. 2015 ; Vol. 6, No. 12. pp. 1231-1235.
@article{22ac464e16c0447590669659263714fb,
title = "Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis",
abstract = "mPTPB is a virulent phosphatase from Mycobacterium tuberculosis and a promising therapeutic target for tuberculosis. To facilitate mPTPB-based drug discovery, we identified α-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation β-lactam cephalosporin antibiotic, as a novel pTyr pharmacophore for mPTPB. Structure-guided and fragment-based optimization of SPAA led to the most potent and selective mPTPB inhibitor 9, with a Ki of 7.9 nM and more than 10,000-fold preference for mPTPB over a large panel of 25 phosphatases. Compound 9 also exhibited excellent cellular activity and specificity in blocking mPTPB function in macrophage. Given its novel structure, modest molecular mass, and extremely high ligand efficiency (0.46), compound 9 represents an outstanding lead compound for anti-TB drug discovery targeting mPTPB.",
keywords = "antituberculosis, mPTPB inhibitor, Protein tyrosine phosphatase, pTyr mimetics",
author = "Rongjun He and Yu, {Zhi Hong} and Zhang, {Ruo Yu} and Li Wu and Gunawan, {Andrea M.} and Zhong-Yin Zhang",
year = "2015",
month = "12",
day = "10",
doi = "10.1021/acsmedchemlett.5b00373",
language = "English (US)",
volume = "6",
pages = "1231--1235",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis

AU - He, Rongjun

AU - Yu, Zhi Hong

AU - Zhang, Ruo Yu

AU - Wu, Li

AU - Gunawan, Andrea M.

AU - Zhang, Zhong-Yin

PY - 2015/12/10

Y1 - 2015/12/10

N2 - mPTPB is a virulent phosphatase from Mycobacterium tuberculosis and a promising therapeutic target for tuberculosis. To facilitate mPTPB-based drug discovery, we identified α-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation β-lactam cephalosporin antibiotic, as a novel pTyr pharmacophore for mPTPB. Structure-guided and fragment-based optimization of SPAA led to the most potent and selective mPTPB inhibitor 9, with a Ki of 7.9 nM and more than 10,000-fold preference for mPTPB over a large panel of 25 phosphatases. Compound 9 also exhibited excellent cellular activity and specificity in blocking mPTPB function in macrophage. Given its novel structure, modest molecular mass, and extremely high ligand efficiency (0.46), compound 9 represents an outstanding lead compound for anti-TB drug discovery targeting mPTPB.

AB - mPTPB is a virulent phosphatase from Mycobacterium tuberculosis and a promising therapeutic target for tuberculosis. To facilitate mPTPB-based drug discovery, we identified α-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation β-lactam cephalosporin antibiotic, as a novel pTyr pharmacophore for mPTPB. Structure-guided and fragment-based optimization of SPAA led to the most potent and selective mPTPB inhibitor 9, with a Ki of 7.9 nM and more than 10,000-fold preference for mPTPB over a large panel of 25 phosphatases. Compound 9 also exhibited excellent cellular activity and specificity in blocking mPTPB function in macrophage. Given its novel structure, modest molecular mass, and extremely high ligand efficiency (0.46), compound 9 represents an outstanding lead compound for anti-TB drug discovery targeting mPTPB.

KW - antituberculosis

KW - mPTPB inhibitor

KW - Protein tyrosine phosphatase

KW - pTyr mimetics

UR - http://www.scopus.com/inward/record.url?scp=84949766668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949766668&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.5b00373

DO - 10.1021/acsmedchemlett.5b00373

M3 - Article

AN - SCOPUS:84949766668

VL - 6

SP - 1231

EP - 1235

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 12

ER -